中文名稱(chēng):兔抗BMPR2多克隆抗體
Background: |
This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. |
Applications: |
ELISA, IHC |
Name of antibody: |
BMPR2 |
Immunogen: |
Fusion protein of human BMPR2 |
Full name: |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
Synonyms: |
BMR2; PPH1; BMPR3; BRK-3; T-ALK; BMPR-II |
SwissProt: |
Q13873 |
ELISA Recommended dilution: |
2000-5000 |
IHC positive control: |
Human esophagus cancer |
IHC Recommend dilution: |
25-100 |